1. Loss of p27 Expression Through RAS->BRAF->MAP Kinase-Dependent Pathway in Human Thyroid Carcinomas
- Author
-
Massimo Santoro, Silvia De Gisi, Angela Persico, Donatella Malanga, Gennaro Chiappetta, Carmela De Marco, Maria Letizia Motti, Giancarlo Troncone, Daniela Califano, Giuseppe Viglietto, Simona Losito, Alfredo Fusco, Fernanda Fabiani, Motti, Ml, Marco, Cd, Califano, D, Gisi, Sd, Malanga, D, Troncone, Giancarlo, Persico, A, Losito, S, Fabiani, F, Santoro, Massimo, Fusco, Alfredo, and Viglietto, G.
- Subjects
Proto-Oncogene Proteins B-raf ,endocrine system diseases ,MAP Kinase Signaling System ,thyroid ,Cell Line, Tumor ,medicine ,SKP2 ,Humans ,Thyroid Neoplasms ,Molecular Biology ,Thyroid cancer ,Thyroid hormone receptor ,biology ,Oncogene ,Cell growth ,Thyroid ,Cell Biology ,medicine.disease ,Gene Expression Regulation, Neoplastic ,Genes, ras ,medicine.anatomical_structure ,Mitogen-activated protein kinase ,biology.protein ,Cancer research ,cell cycle ,Mitogen-Activated Protein Kinases ,ra ,Cyclin-Dependent Kinase Inhibitor p27 ,braf ,Developmental Biology - Abstract
In the present study, we report that the RAS/BRAF/MAP kinase cascade plays a crucial role in the regulation of the Skp2/p27 pathway in thyroid cancer cells and that this is critical for cell proliferation. In vitro studies with cellular models of human thyroid carcinoma cells demonstrated that the adoptive expression of oncogenic RET/PTC1, Ha-RASV12 or BRAFV600E enhances Skp2 and reduces p27 protein expression in a MAP kinase-dependent manner; that RAS/BRAF/MAP kinase-dependent control of p27 expression in thyroid cancer cells occurs by regulating the stability of Skp2 and p27 protein; and that antisense oligonucleotides to p27 suppress growth arrest induced by MEK inhibitors. Finally, analysis of human thyroid carcinomas indicated that MAP kinase-positive thyroid tumors-as detected by immunostaining for p-ERK - presented high p27 degradative activity and low levels of p27 protein (n = 30; p < 0.05). In summary, our results indicate that constitutive signalling of the MAP kinase cascade contributes to the development of thyroid cancer promoted by activated RAS and BRAF oncogenes and that this occurs, at least in part, by compromising the inhibitory function of p27.
- Published
- 2007